Original document(16 pages)  中文版
    A hydroxy apatite marked by the nanoparticles of near-infrared fluorescent quantum point for researching the growth of bone and diagnosing and treating the diseases, such as coronary sclerosis, bone cancer, etc is prepared by linking the nanoparticles of near-infrared fluorescent quantum point with the hydroxy opatite via adsorption, ion exchange, or covalent bonding.
Application Number
申请号		 200510025590 Application Date
申请日		 2005.04.29
Title 名称 Hydroxy phosphorite of near infrared fluorescence quantum point mark and its preparation process and application
Publication Number
公开号		 1693410 Publication Date
公开日		 2005.11.09
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C09K11/00,A61K49/00,A61K51/00,A61P35/00
Applicant(s) Name
申请人		 Tongji Univ.
Address 地址 200092
Inventor(s) Name 发明人 Chu Maoquan
Attorney & Agent 代理人 du linxue

  
Tanshinone solid disperser and its prepn. method
Micropowdered tanshinone preparation and its microwave aided co-grinding process for preparing it
Spherical lipid powder of tanshinone precursor and its preparing process
Prepn of core-shell type nano compound hydroxyapatiti-liposome particle
Liposome and inorganic material core-shell type nano composite particle and its preparation method and application
Preparation method of nucleous-shell type nanometer composite particle of magnetic micro particle and quantum point
Preparation method of quantum point microspheric for bio-medical fluorescence probe
Method for preparing fluorescent spectrum adjustable quantum dot nano composite particle
Fluorescent microball and process and application for preparing spray drying thereof
Method for quantum dots namo fluorescence probe combined with biochip to find Chinese medicine target
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.